These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16008004)

  • 81. A rational approach to single, dual and triple therapy in COPD.
    Calverley P; Vlies B
    Respirology; 2016 May; 21(4):581-9. PubMed ID: 26611377
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs.
    Yawn BP; Kim V
    Cleve Clin J Med; 2018 Feb; 85(2 Suppl 1):S28-S37. PubMed ID: 29494330
    [No Abstract]   [Full Text] [Related]  

  • 83. A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice?
    Papi A
    Respir Med; 2012 Dec; 106 Suppl 1():S1-3. PubMed ID: 23273162
    [No Abstract]   [Full Text] [Related]  

  • 84. [Combining LABA and ICS in patients with severe COPD].
    Parameswaran K; Jaeschke R; O'Byrne PM
    Pol Arch Med Wewn; 2007; 117(1-2):6-8. PubMed ID: 17642199
    [No Abstract]   [Full Text] [Related]  

  • 85. [Drugs for chronic obstructive pulmonary disorder].
    Bakke PS; Høines KJ
    Tidsskr Nor Laegeforen; 2019 Oct; 139(14):. PubMed ID: 31592602
    [No Abstract]   [Full Text] [Related]  

  • 86. [2 step inhaler for twice daily use].
    Einecke D
    MMW Fortschr Med; 2015 Mar; 157(4):68. PubMed ID: 25743988
    [No Abstract]   [Full Text] [Related]  

  • 87. [Inhaled corticosteroids. Essential in asthma, problematic in COPD].
    MMW Fortschr Med; 2014 Feb; 156(2):26. PubMed ID: 24934041
    [No Abstract]   [Full Text] [Related]  

  • 88. [Beta 2 agonists between the FDA, Cochrane and reality].
    Mihălţan F; Ulmeanu R
    Pneumologia; 2009; 58(1):4-5, 7. PubMed ID: 19507479
    [No Abstract]   [Full Text] [Related]  

  • 89. To add, or not to add an inhaled corticosteroid in moderate COPD: that is the question.
    Cazzola M; Matera MG
    Chest; 2008 Aug; 134(2):223-225. PubMed ID: 18682451
    [No Abstract]   [Full Text] [Related]  

  • 90. Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD?
    Hamilton T; Miller JB; Vincent EC; St Anna L
    J Fam Pract; 2014 May; 63(5):276-8. PubMed ID: 24795909
    [No Abstract]   [Full Text] [Related]  

  • 91. [Bronchodilator treatment of COPD].
    Naberan K
    Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
    [No Abstract]   [Full Text] [Related]  

  • 92. Comparison table: Inhaled short-acting bronchodilators for treatment of COPD.
    Med Lett Drugs Ther; 2020 Sep; 62(1606):e144-e145. PubMed ID: 32960873
    [No Abstract]   [Full Text] [Related]  

  • 93. Inhaled glucocorticoids and COPD exacerbations.
    Cosio M; Baraldo S; Saetta M
    N Engl J Med; 2015 Jan; 372(1):92. PubMed ID: 25551536
    [No Abstract]   [Full Text] [Related]  

  • 94. Inhaled corticosteroid containing combinations and mortality in COPD.
    Vestbo J; Fabbri L; Papi A; Petruzzelli S; Scuri M; Guasconi A; Vezzoli S; Singh D
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30209195
    [No Abstract]   [Full Text] [Related]  

  • 95. Discontinuing inhaled steroids might not be safe in severe COPD cases.
    Laniado-Laborín R
    Evid Based Med; 2015 Apr; 20(2):57. PubMed ID: 25595701
    [No Abstract]   [Full Text] [Related]  

  • 96. Airway blood flow reactivity in smokers.
    Wanner A; Campos MA; Mendes E
    Pulm Pharmacol Ther; 2007; 20(2):126-9. PubMed ID: 16414297
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease.
    Cooper CB; Tashkin DP
    BMJ; 2005 Mar; 330(7492):640-4. PubMed ID: 15774995
    [No Abstract]   [Full Text] [Related]  

  • 98. [Novel drugs for COPD treatment].
    Gillissen A
    Pneumologie; 2014 Sep; 68(9):594-8. PubMed ID: 25003907
    [TBL] [Abstract][Full Text] [Related]  

  • 99. ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD.
    Shafazand S
    Ann Intern Med; 2013 Jun; 158(12):JC2. PubMed ID: 23778926
    [No Abstract]   [Full Text] [Related]  

  • 100. Inhaled steroids and outcomes in COPD: progressing beyond FEV1.
    Sutherland ER
    Chest; 2007 Mar; 131(3):648-9. PubMed ID: 17356076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.